A THAOS Sub-Study Evaluating the Effects of Tafamidis on Disease Progression in Patients with non-V30M Mutations and Symptomatic Neuropathy

First published 30/05/2013

Last updated 14/03/2024

EU PAS number:

EUPAS4027

Study

Finalised

Documents

Study protocol

Initial protocol

B3461029 Tafamidis THAOS Substudy Protocol

English (526.91 KB - PDF)View document

Updated protocol

B3461029 THAOS Substudy Protocol Amendment #1

First published: 22/02/2024

English (673.59 KB - PDF)View document

Study results

B3461029 CT24-GSOP-RF26 1.0 NI Study Report Abstract

English (1.21 MB - PDF)View document

Study report

B3461029 CT24-GSOP-RF27 1.0 NI Study Report (1)

English (2.23 MB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs